79175767 - D

Information

  • Trademark
  • 79175767
  • Serial Number
    79175767
  • Registration Number
    5293325
  • Filing Date
    December 29, 2014
    10 years ago
  • Registration Date
    September 26, 2017
    7 years ago
  • Transaction Date
    January 23, 2025
    a month ago
  • Status Date
    May 23, 2024
    9 months ago
  • Published for Opposition Date
    November 08, 2016
    8 years ago
  • Location Date
    May 23, 2024
    9 months ago
  • Status Code
    708
  • Current Location
    Historical data usage
    Employee Name
    THOMAS, JULIE
  • Attorney Docket Number
    363810021US1
    Attorney Name
    Kristen McCallion
    Law Office Assigned Location Code
    L70
  • Owners
Mark Drawing Code
3
Mark Identification
D
Case File Statements
  • GS0411: [ Entertainment television news programme services in the field of pharmaceutical products and sanitary preparations for medical purposes broadcast over the internet; organizing community festivals featuring primarily pharmaceutical exhibition for medical purposes; arranging professional workshop and training courses in the field of pharmaceutical products and medicine for medical purposes; training services in the field of pharmaceutical and sanitary preparations for medical purposes; education service, namely, providing tutoring in the field of pharmaceutical and sanitary preparations for medical purposes; providing information relating to organizing community cultural activities and contests ]
  • DM0000: The mark consists of a black-outlined, red hexagon with a white letter "D" in the center.
  • GS0051: [Pharmaceutical preparation for the treatment of respiratory diseases; pharmaceutical preparation for the treatment of bone diseases; analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; anti-epileptic pharmaceutical preparations; balms for pharmaceutical purposes; capsules sold empty for pharmaceuticals; cardiovascular pharmaceuticals; gelatin capsules sold empty for pharmaceuticals;] ocular pharmaceuticals; pharmaceutical products for ophthalmological use [ ; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases also rare; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical antitussive cold pharmaceutical preparations for use in chemotherapy; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in tissue and organ transplantation also rare; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for treating diabetes also rare; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; sanitary preparations for medical purposes; all-purpose disinfectants ]
  • PM0001: DOMPE
  • CC0000: The color(s) black, red and white is/are claimed as a feature of the mark.
  • GS0421: Conducting early evaluations in the field of new pharmaceuticals; conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology, treatment of cancer, diabetes, analgesic preparations, nerve grow factors, oncology, organ transplantation, antibiotics, respiratory diseases, bone diseases, rare diseases; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, medical diagnostics, drug development and pharmacogenetics; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; research and development of pharmaceuticals for the treatment of cancer, diabetes, respiratory diseases, bone diseases, rare diseases, ocular disorders and diseases; research and development in the pharmaceutical and biotechnology fields
Case File Event Statements
  • 11/7/2015 - 9 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 11/9/2015 - 9 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 11/10/2015 - 9 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/10/2015 - 9 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/14/2015 - 9 years ago
    5 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 11/25/2015 - 9 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/26/2015 - 9 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 12/1/2015 - 9 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/1/2015 - 9 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 12/18/2015 - 9 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 4/28/2016 - 8 years ago
    11 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 6/1/2016 - 8 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/1/2016 - 8 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/2/2016 - 8 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/30/2016 - 8 years ago
    15 - FINAL REFUSAL WRITTEN Type: CNFR
  • 6/30/2016 - 8 years ago
    16 - FINAL REFUSAL E-MAILED Type: GNFR
  • 6/30/2016 - 8 years ago
    17 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 9/28/2016 - 8 years ago
    18 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 9/28/2016 - 8 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/28/2016 - 8 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/28/2016 - 8 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/19/2016 - 8 years ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/19/2016 - 8 years ago
    23 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 10/19/2016 - 8 years ago
    24 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 11/8/2016 - 8 years ago
    25 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/8/2016 - 8 years ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/18/2016 - 8 years ago
    27 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 12/7/2016 - 8 years ago
    28 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 4/5/2017 - 7 years ago
    29 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 4/5/2017 - 7 years ago
    30 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 5/9/2017 - 7 years ago
    31 - OPPOSITION NOTICE (IB REFUSAL) CREATED Type: OPNC
  • 5/9/2017 - 7 years ago
    32 - OPPOSITION NOTICE (IB REFUSAL) SENT TO IB Type: OPNS
  • 5/10/2017 - 7 years ago
    33 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 5/12/2017 - 7 years ago
    34 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 6/3/2017 - 7 years ago
    35 - REFUSAL PROCESSED BY IB Type: RFNT
  • 8/21/2017 - 7 years ago
    37 - OPPOSITION TERMINATED NO. 999999 Type: OP.T
  • 8/21/2017 - 7 years ago
    36 - OPPOSITION DISMISSED NO. 999999 Type: OP.D
  • 8/21/2017 - 7 years ago
    38 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN
  • 9/26/2017 - 7 years ago
    39 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/26/2017 - 7 years ago
    40 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 12/29/2017 - 7 years ago
    41 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 12/29/2017 - 7 years ago
    42 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 1/26/2018 - 7 years ago
    43 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 2/12/2021 - 4 years ago
    44 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 6/4/2021 - 3 years ago
    45 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 9/26/2022 - 2 years ago
    46 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 9/26/2023 - a year ago
    47 - TEAS SECTION 71 & 15 RECEIVED Type: ES75
  • 5/20/2024 - 9 months ago
    48 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 5/23/2024 - 9 months ago
    49 - REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. Type: C75P
  • 5/23/2024 - 9 months ago
    50 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Type: NA75
  • 1/2/2025 - 2 months ago
    51 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL
  • 1/23/2025 - a month ago
    52 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR